Searchable abstracts of presentations at key conferences in endocrinology

ea0081p228 | Thyroid | ECE2022

When patients with DTC can be discharged to primary care

Amich Nicolas , Chumbiauca Estefania , Carlos Galofre Juan

Purpose: To evaluate if patients with low- or intermediate-risk differentiated thyroid cancer (DTC) can be discharged to primary care.Material and Methods: The clinical records and evolution of 346 patients with DTC who had undergone surgery between 1995 and 2020 with a follow-up after a mean of 7.6 ± 6.1 years were retrospectively reviewed. All had a low or intermediate risk of recurrence as defined under the 2015 ATA risk stratification system and...

ea0081p238 | Thyroid | ECE2022

The use of body composition measured by CUN-BAE as a simple tool to predict the LT4 titration after total thyroidectomy in patients with benign and malignant thyroid disease

Maria Diaz Abram Ana , Chumbiauca Estefania , Carlos Galofre Juan

Background: Patients who require levothyroxine (LT4) supplementation after total thyroidectomy often have difficulty achieving target TSH levels. Several studies have attempted to develop a dosing schedule considering different factors such as age, gender, weight, or body mass index (BMI) as potential determinants of the correct dose of LT4. The objective of this study is to determine if a scheme that uses the percentage of body fat (%BF) measured by CUN-BAE is more accurate t...

ea0092ps2-16-03 | Thyroid Cancer clinical 2 | ETA2023

The incidence of thyroid cancer in europe: A meta-analysis

De Villalonga Beatriz , Volpi Federico , Chumbiauca Estefania , Garcia Marta , Guillen-Grima Francisco , Carlos Galofre Juan

Background: The incidence of thyroid cancer (TC) has been increasing in recent years while mortality has remained stable. The cause of this increase is unclear, although several hypotheses have been proposed. While the increased incidence may only be apparent due to increased testing, there is data that suggest that there may be a real increase in incidence related to different risk factors. The aim of this meta-analysis was to determine the current incidence of TC in Europe.<...

ea0081ep961 | Thyroid | ECE2022

Use of thyroid hormone in hypothyroid and euthyroid patients. the THESIS questionnaire survey in spain

Carlos Galofre Juan , Attanasio Roberto , Hegedus Laszlo , Nagy Endre V. , Negro Roberto , Papini Enrico , Perros Petros , Diez Juan Jose

Background: Hypothyroidism is one of the most frequent conditions in endocrinology. Despite of that fact, indications for treatment differ among specialists in Spain.Aims: To identify attitudes of Spanish endocrinologists in the use of levothyroxine (LT4) therapy and the management of hypothyroidism.Methods: The members of the Sociedad Española de Endocrinología y Nutrición (Spanish Society of Endocrinology ...

ea0092ps1-03-03 | Miscellaneous 1 | ETA2023

Treatment of obesity with thyroid hormones: data from the thesis* collaboration. *treatment of hypothyroidism in europe by specialists, an international survey

Carlos Galofre Juan , Jose Diez Juan , Attanasio Roberto , Nagy Endre , Negro Roberto , Papini Enrico , Perros Petros , Zarkovic Milos , Hegedus Laszlo

Objectives: The use of thyroid hormones (TH) to treat obesity is not supported by evidence based on efficacy and safety, and this is reflected in recommendations of major international guidelines on hypothyroidism and obesity. We aimed to explore views about this practice among European thyroid specialists and their associations with respondent characteristics.Methods: Thyroid specialists from 28 countries were invited to participate in a questionnaire s...

ea0092ps1-03-04 | Miscellaneous 1 | ETA2023

Association between immune-related thyroid dysfunction and the efficacy of immune checkpoint inhibitors

Garcia Marta , Carlos Galofre Juan , Vazquez Beatriz , Fernandez de Sanmamed Miguel , Olmedo Maria , Chumbiauca Estefania , Martin-Calvo Nerea

Introduction: Immune checkpoint inhibitors (ICIs) are an effective treatment for advanced cancer, but they are not free from immune-related adverse events (irAEs). A common irAES is thyroid dysfunction (TD-irAEs) and, as such, may influence patient survival and response to ICIs.Objetives: The aim was to determine the incidence and characteristics of TD-irAEs among patients with advanced cancer treated with ICIs in a real-life setting and to investigate t...